Clinical Trial Update: Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating whether adding interleukin-2 to surgery and radiation improves outcomes for mouth and oropharyngeal cancers; the current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Mouth Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: European Institute of Oncology | Conditions: Head and Neck Cancer | Phase 3 | Status: UNKNOWN